Workflow
和邦生物(603077) - 2023 Q1 - 季度财报
HBCHBC(SH:603077)2023-04-28 16:00

Financial Performance - The company's operating revenue for Q1 2023 was ¥2,394,468,174.84, a decrease of 22.41% compared to the same period last year[4] - Net profit attributable to shareholders was ¥396,561,190.75, down 61.97% year-on-year[4] - The net cash flow from operating activities was ¥347,430,102.23, reflecting a decline of 42.92% compared to the previous year[4] - Basic and diluted earnings per share were both ¥0.0455, representing a decrease of 62.08% year-on-year[4] - The weighted average return on equity was 2.05%, a decrease of 4.83 percentage points from the previous year[4] - The company experienced a significant decline in sales volume and gross profit, impacting overall financial performance[7] - The net profit for Q1 2023 was CNY 381,460,623.90, a decrease of 63.5% compared to CNY 1,045,126,299.13 in Q1 2022[18] - Operating profit for Q1 2023 was CNY 477,206,214.04, down 61.2% from CNY 1,230,073,011.36 in the same period last year[18] - Total revenue from operating activities was CNY 1,914,538,269.42, a decline from CNY 2,202,926,260.42 in Q1 2022[22] - The company reported a decrease in total comprehensive income to CNY 370,228,317.28, compared to CNY 1,045,773,792.08 in the previous year[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥24,037,510,067.91, a slight decrease of 0.27% from the end of the previous year[5] - The total assets as of March 31, 2023, were CNY 24,037,510,067.91, a slight decrease from CNY 24,102,627,180.48 at the end of 2022[16] - The total liabilities decreased to CNY 3,867,668,111.54 from CNY 4,339,408,910.04, indicating a reduction of about 10.8%[15] - The total liabilities amounted to 4,340,960,469.09 RMB, with a slight increase of 1,551,559.05 RMB from the previous reporting period[26] - The total current assets were reported at 9,718,871,752.72 RMB, consistent with the previous period[25] Shareholder Equity - Shareholders' equity attributable to the parent company increased by 2.21% to ¥19,541,572,552.22 compared to the end of the previous year[5] - The company's equity attributable to shareholders increased to CNY 19,541,572,552.22 from CNY 19,118,356,709.62, reflecting a growth of approximately 2.2%[16] - The total equity attributable to shareholders was 19,118,356,709.62 RMB, remaining stable compared to the previous period[26] Cash Flow and Expenses - Cash flow from operating activities netted CNY 347,430,102.23, down 42.9% from CNY 608,684,674.99 in Q1 2022[22] - The total amount of cash received from sales and services was CNY 1,831,836,825.36, down from CNY 2,150,617,492.61 in Q1 2022[20] - The company incurred financial expenses of CNY 4,888,913.82, a decrease from CNY 7,822,077.06 in the same quarter last year[18] - The company reported a significant reduction in tax expenses to CNY 95,123,195.45 from CNY 182,502,911.84 in the previous year[18] - The net cash flow from financing activities for Q1 2023 was -192,397,264.30 RMB, a significant decrease compared to 705,492,807.09 RMB in Q1 2022[23] - The total cash and cash equivalents at the end of Q1 2023 amounted to 4,521,617,841.20 RMB, down from 2,743,067,767.20 RMB at the end of Q1 2022[23] - The net increase in cash and cash equivalents for Q1 2023 was -23,240,242.97 RMB, contrasting with an increase of 1,062,070,010.26 RMB in Q1 2022[23] Inventory and Receivables - Accounts receivable increased to CNY 967,737,627.47 in Q1 2023 from CNY 777,990,967.77 in Q1 2022, reflecting a growth of about 24.4%[14] - Inventory as of March 31, 2023, was CNY 2,340,898,666.66, compared to CNY 2,076,049,121.12 in the previous year, marking an increase of approximately 12.7%[14] - The company's inventory stood at 2,076,049,121.12 RMB, unchanged from the previous reporting period[25] - The total amount of accounts receivable was reported at 777,990,967.77 RMB, remaining stable compared to the previous period[24] Research and Development - Research and development expenses increased to CNY 9,108,322.93, up 18.7% from CNY 7,666,274.21 in Q1 2022[18] Production Developments - The company is progressing with the development of a 1,000t/d photovoltaic glass panel production line, which has officially commenced production[11]